S&P 500   3,962.64 (+1.57%)
DOW   31,856.83 (+1.90%)
QQQ   290.75 (+0.72%)
AAPL   141.78 (+3.05%)
MSFT   259.33 (+2.68%)
FB   193.78 (+0.12%)
GOOGL   2,215.55 (+1.72%)
AMZN   2,099.94 (-2.41%)
TSLA   662.10 (-0.27%)
NVDA   165.58 (-0.81%)
BABA   86.34 (-0.52%)
NIO   15.60 (-5.11%)
AMD   93.55 (+0.05%)
CGC   5.16 (-6.52%)
MU   68.84 (-0.09%)
T   20.74 (+1.67%)
GE   75.37 (+0.16%)
F   12.73 (+1.84%)
DIS   104.44 (+1.97%)
AMC   11.61 (-3.49%)
PFE   52.91 (+0.84%)
PYPL   80.64 (+0.12%)
NFLX   184.24 (-1.13%)
S&P 500   3,962.64 (+1.57%)
DOW   31,856.83 (+1.90%)
QQQ   290.75 (+0.72%)
AAPL   141.78 (+3.05%)
MSFT   259.33 (+2.68%)
FB   193.78 (+0.12%)
GOOGL   2,215.55 (+1.72%)
AMZN   2,099.94 (-2.41%)
TSLA   662.10 (-0.27%)
NVDA   165.58 (-0.81%)
BABA   86.34 (-0.52%)
NIO   15.60 (-5.11%)
AMD   93.55 (+0.05%)
CGC   5.16 (-6.52%)
MU   68.84 (-0.09%)
T   20.74 (+1.67%)
GE   75.37 (+0.16%)
F   12.73 (+1.84%)
DIS   104.44 (+1.97%)
AMC   11.61 (-3.49%)
PFE   52.91 (+0.84%)
PYPL   80.64 (+0.12%)
NFLX   184.24 (-1.13%)
S&P 500   3,962.64 (+1.57%)
DOW   31,856.83 (+1.90%)
QQQ   290.75 (+0.72%)
AAPL   141.78 (+3.05%)
MSFT   259.33 (+2.68%)
FB   193.78 (+0.12%)
GOOGL   2,215.55 (+1.72%)
AMZN   2,099.94 (-2.41%)
TSLA   662.10 (-0.27%)
NVDA   165.58 (-0.81%)
BABA   86.34 (-0.52%)
NIO   15.60 (-5.11%)
AMD   93.55 (+0.05%)
CGC   5.16 (-6.52%)
MU   68.84 (-0.09%)
T   20.74 (+1.67%)
GE   75.37 (+0.16%)
F   12.73 (+1.84%)
DIS   104.44 (+1.97%)
AMC   11.61 (-3.49%)
PFE   52.91 (+0.84%)
PYPL   80.64 (+0.12%)
NFLX   184.24 (-1.13%)
S&P 500   3,962.64 (+1.57%)
DOW   31,856.83 (+1.90%)
QQQ   290.75 (+0.72%)
AAPL   141.78 (+3.05%)
MSFT   259.33 (+2.68%)
FB   193.78 (+0.12%)
GOOGL   2,215.55 (+1.72%)
AMZN   2,099.94 (-2.41%)
TSLA   662.10 (-0.27%)
NVDA   165.58 (-0.81%)
BABA   86.34 (-0.52%)
NIO   15.60 (-5.11%)
AMD   93.55 (+0.05%)
CGC   5.16 (-6.52%)
MU   68.84 (-0.09%)
T   20.74 (+1.67%)
GE   75.37 (+0.16%)
F   12.73 (+1.84%)
DIS   104.44 (+1.97%)
AMC   11.61 (-3.49%)
PFE   52.91 (+0.84%)
PYPL   80.64 (+0.12%)
NFLX   184.24 (-1.13%)
LON:CTEC

ConvaTec Group (CTEC) Share Forecast, Price & News

GBX 217.80
+0.60 (+0.28%)
(As of 05/23/2022 04:45 PM ET)
Add
Compare
Today's Range
217.40
222
50-Day Range
183.30
225.20
52-Week Range
165.30
265
Volume
1.89 million shs
Average Volume
3.99 million shs
Market Capitalization
£4.43 billion
P/E Ratio
47.35
Dividend Yield
2.02%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CTEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

ConvaTec Group logo

About ConvaTec Group

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,142
Year Founded
N/A

Sales & Book Value

Annual Sales
£2.04 billion
Cash Flow
GBX 23.06 per share
Book Value
GBX 84.20 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
2,034,573,000
Free Float
N/A
Market Cap
£4.43 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
2/28/2020
Ex-Dividend for 5/19 Dividend
3/31/2022
Dividend Payable
5/19/2022
Today
5/23/2022
Next Earnings (Estimated)
8/04/2022

MarketRank

Overall MarketRank

2.00 out of 5 stars

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -













ConvaTec Group (LON:CTEC) Frequently Asked Questions

Is ConvaTec Group a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ConvaTec Group stock.
View analyst ratings for ConvaTec Group
or view top-rated stocks.

When is ConvaTec Group's next earnings date?

ConvaTec Group is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for ConvaTec Group
.

How were ConvaTec Group's earnings last quarter?

ConvaTec Group Plc (LON:CTEC) announced its earnings results on Friday, February, 28th. The company reported $12.00 earnings per share for the quarter, missing the consensus estimate of $12.70 by $0.70.
View ConvaTec Group's earnings history
.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Tuesday, March 8th. Stockholders of record on Thursday, March 31st will be given a dividend of GBX 3.16 per share on Thursday, May 19th. This represents a yield of 1.81%. The ex-dividend date of this dividend is Thursday, March 31st. This is an increase from ConvaTec Group's previous dividend of GBX 1.23. The official announcement can be accessed at this link.
View ConvaTec Group's dividend history
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group pays an annual dividend of GBX 0.06 per share and currently has a dividend yield of 2.02%. The dividend payout ratio of ConvaTec Group is 1.22%. This payout ratio is at a healthy, sustainable level, below 75%.
View ConvaTec Group's dividend history.

What price target have analysts set for CTEC?

8 brokers have issued twelve-month price objectives for ConvaTec Group's stock. Their forecasts range from GBX 210 to GBX 310. On average, they anticipate ConvaTec Group's share price to reach GBX 248.57 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts' price targets for ConvaTec Group
or view top-rated stocks among Wall Street analysts.

Who are ConvaTec Group's key executives?
ConvaTec Group's management team includes the following people:
  • Mr. Karim Bitar, CEO & Director (Age 57, Pay $3.48M)
  • Mr. Frank M. Schulkes, Exec. Officer (Age 60, Pay $1.08M)
  • Mr. Jonathan P. Mason, Group CFO & Director (Age 58)
  • Mr. Donal Balfe, Exec. VP and Chief of Quality & Operations
  • Dr. Divakar Ramakrishnan Ph.D., Exec. VP & Chief Technology Officer
  • Mr. Mark Reynolds, Director of Investor Relations
  • Ms. Kate Postans, VP of Investor Relations & Corp. Communications
  • Ms. Natalia Kozmina, Exec. VP & Chief HR Officer
  • Mr. Christian Hoengaard, Sr. VP & GM - USA
  • Ms. Kjersti Grimsrud Biotechnology, M.Sc., Pres & COO of Infusion Care (Age 61)
What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC).

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

How do I buy shares of ConvaTec Group?

Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ConvaTec Group's stock price today?

One share of CTEC stock can currently be purchased for approximately GBX 217.80.

How much money does ConvaTec Group make?

ConvaTec Group has a market capitalization of £4.43 billion and generates £2.04 billion in revenue each year.

How many employees does ConvaTec Group have?

ConvaTec Group employs 10,142 workers across the globe.

What is ConvaTec Group's official website?

The official website for ConvaTec Group is www.convatecgroup.com.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.